Literature DB >> 25984423

Diagnosis of idiopathic pulmonary fibrosis: Current issues.

Rajendra Prasad1, Nikhil Gupta2, Abhijeet Singh1, Pawan Gupta1.   

Abstract

Idiopathic pulmonary fibrosis (IPF) accounts for the majority of lung diseases classified as idiopathic interstitial pneumonia (IIP). It is considered to be lethal because prognosis is very poor and far worse than other types of IIP. An early and accurate diagnosis of IPF is critical. The diagnostic process is complex and requires a multidisciplinary approach involving a pulmonologist, radiologist and pathologist.

Entities:  

Keywords:  Idiopathic pulmonary fibrosis; diagnosis; idiopathic interstitial pneumonia

Year:  2015        PMID： 25984423      PMCID： PMC4428188          DOI： 10.5582/irdr.2015.01009

Source DB:  PubMed          Journal:  Intractable Rare Dis Res        ISSN： 2186-3644


  34 in total

Review 1.  American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS).

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2000-02       Impact factor: 21.405

2.  Diffuse lung disease: diagnostic accuracy of CT in patients undergoing surgical biopsy of the lung.

Authors:  S J Swensen; G L Aughenbaugh; J L Myers
Journal:  Radiology       Date:  1997-10       Impact factor: 11.105

3.  Transbronchial biopsy in usual interstitial pneumonia.

Authors:  Ema A Berbescu; Anna-Luise A Katzenstein; Jennifer L Snow; David A Zisman
Journal:  Chest       Date:  2006-05       Impact factor: 9.410

4.  Incidence and prevalence of idiopathic pulmonary fibrosis.

Authors:  Ganesh Raghu; Derek Weycker; John Edelsberg; Williamson Z Bradford; Gerry Oster
Journal:  Am J Respir Crit Care Med       Date:  2006-06-29       Impact factor: 21.405

5.  Increased levels of KL-6 and subsequent mortality in patients with interstitial lung diseases.

Authors:  H Satoh; K Kurishima; H Ishikawa; M Ohtsuka
Journal:  J Intern Med       Date:  2006-11       Impact factor: 8.989

6.  Idiopathic pulmonary fibrosis. Epidemiologic approaches to occupational exposure.

Authors:  K Iwai; T Mori; N Yamada; M Yamaguchi; Y Hosoda
Journal:  Am J Respir Crit Care Med       Date:  1994-09       Impact factor: 21.405

7.  The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: A prospective study.

Authors:  G Raghu; Y N Mageto; D Lockhart; R A Schmidt; D E Wood; J D Godwin
Journal:  Chest       Date:  1999-11       Impact factor: 9.410

8.  Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK.

Authors:  J Gribbin; R B Hubbard; I Le Jeune; C J P Smith; J West; L J Tata
Journal:  Thorax       Date:  2006-07-14       Impact factor: 9.139

9.  Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis.

Authors:  Charlene D Fell; Fernando J Martinez; Lyrica X Liu; Susan Murray; Meilan K Han; Ella A Kazerooni; Barry H Gross; Jeffrey Myers; William D Travis; Thomas V Colby; Galen B Toews; Kevin R Flaherty
Journal:  Am J Respir Crit Care Med       Date:  2010-01-07       Impact factor: 21.405

10.  High serum concentrations of surfactant protein A in usual interstitial pneumonia compared with non-specific interstitial pneumonia.

Authors:  H Ishii; H Mukae; J Kadota; H Kaida; T Nagata; K Abe; S Matsukura; S Kohno
Journal:  Thorax       Date:  2003-01       Impact factor: 9.139
View more
  8 in total

Review 1.  The Role and Immunobiology of Eosinophils in the Respiratory System: a Comprehensive Review.

Authors:  Stephanie S Eng; Magee L DeFelice
Journal:  Clin Rev Allergy Immunol       Date:  2016-04       Impact factor: 8.667

2.  p53 Expression in Lung Fibroblasts Is Linked to Mitigation of Fibrotic Lung Remodeling.

Authors:  M R Nagaraja; Nivedita Tiwari; Shwetha K Shetty; Amarnath S Marudamuthu; Liang Fan; Rennolds S Ostrom; Jian Fu; Venkadesaperumal Gopu; Vijay Radhakrishnan; Steven Idell; Sreerama Shetty
Journal:  Am J Pathol       Date:  2018-10       Impact factor: 4.307

3.  Increased Cellular NAD+ Level through NQO1 Enzymatic Action Has Protective Effects on Bleomycin-Induced Lung Fibrosis in Mice.

Authors:  Gi-Su Oh; Su-Bin Lee; Anjani Karna; Hyung-Jin Kim; AiHua Shen; Arpana Pandit; SeungHoon Lee; Sei-Hoon Yang; Hong-Seob So
Journal:  Tuberc Respir Dis (Seoul)       Date:  2016-10-05

4.  Association between pulmonary fibrosis and osteoporosis in the elderly people: A case-control study.

Authors:  Zhong Xie; Yanhong He; Yongqiang Sun; Zhanzhan Lin; Mingzhi Yang; Qian Liu; Sihai Liu
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

Review 5.  Blood Biomarkers in Idiopathic Pulmonary Fibrosis.

Authors:  Julien Guiot; Catherine Moermans; Monique Henket; Jean-Louis Corhay; Renaud Louis
Journal:  Lung       Date:  2017-03-28       Impact factor: 2.584

6.  Design of a Study Assessing Disease Behaviour During the Peri-Diagnostic Period in Patients with Interstitial Lung Disease: The STARLINER Study.

Authors:  Marlies Wijsenbeek; Elisabeth Bendstrup; Claudia Valenzuela; Michael T Henry; Catharina Moor; Monica Bengus; Andras Perjesi; Frank Gilberg; Klaus-Uwe Kirchgaessler; Carlo Vancheri
Journal:  Adv Ther       Date:  2018-11-30       Impact factor: 3.845

7.  Six-SOMAmer Index Relating to Immune, Protease and Angiogenic Functions Predicts Progression in IPF.

Authors:  Shanna L Ashley; Meng Xia; Susan Murray; David N O'Dwyer; Ethan Grant; Eric S White; Kevin R Flaherty; Fernando J Martinez; Bethany B Moore
Journal:  PLoS One       Date:  2016-08-04       Impact factor: 3.240

8.  The Protective Effect of Naringin against Bleomycin-Induced Pulmonary Fibrosis in Wistar Rats.

Authors:  Nergiz H Turgut; Haki Kara; Sahende Elagoz; Koksal Deveci; Huseyin Gungor; Emre Arslanbas
Journal:  Pulm Med       Date:  2016-02-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.